Cost and cost-effectiveness in a randomized trial of long-acting risperidone for schizophrenia

J Clin Psychiatry. 2012 Oct;73(10):1358; author reply 1358-9. doi: 10.4088/JCP.12lr07934.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antipsychotic Agents / economics*
  • Drug Costs*
  • Female
  • Humans
  • Male
  • Psychotic Disorders / drug therapy*
  • Risperidone / economics*
  • Schizophrenia / drug therapy*

Substances

  • Antipsychotic Agents
  • Risperidone